Genetic Signatures Ltd Capital Reinvestment Ratio
Genetic Signatures Ltd capital reinvestment ratio. Genetic Signatures Ltd (GSS) has a Capital Reinvestment Ratio of 1.32x as of June 2022, meaning it reinvests 1% of its operating cash flow (AU$1.93 Million) in capital expenditures (AU$2.55 Million). See GSS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genetic Signatures Ltd (2021–2022)
Capital reinvestment ratio of Genetic Signatures Ltd from 2021 to 2022. This chart tracks Genetic Signatures Ltd's Capital Reinvestment Ratio across 2 annual periods. See GSS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Genetic Signatures Ltd Capital Reinvestment Ratio by Year (2021–2022)
Genetic Signatures Ltd capital reinvestment ratio by year from 2021 to 2022. For the full cash flow conversion analysis, see Genetic Signatures Ltd (GSS) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.30x | AU$9.81 Million | AU$2.99 Million | ▼ -74.3% |
| 2021 | 1.19x | AU$4.20 Million | AU$4.98 Million | — |